The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
SymMap: an integrative database of traditional Chinese medicine enhanced by symptom mapping
Open accessAbstract
Recently, the pharmaceutical industry has heavily emphasized phenotypic drug discovery (PDD), which relies primarily on knowledge about phenotype changes associated with diseases. Traditional Chinese medicine (TCM) provides a massive amount of information on natural products and the clinical symptoms they are used to treat, which are the observable disease phenotypes that are crucial for clinical diagnosis and treatment. Curating knowledge of TCM symptoms and their relationships to herbs and diseases will provide both candidate leads and screening directions for evidence-based PDD programs. Therefore, we present SymMap, an integrative database of traditional Chinese medicine enhanced by symptom mapping. We manually curated 1717 TCM symptoms and related them to 499 herbs and 961 symptoms used in modern medicine based on a committee of 17 leading experts practicing TCM. Next, we collected 5235 diseases associated with these symptoms, 19 595 herbal constituents (ingredients) and 4302 target genes, and built a large heterogeneous network containing all of these components. Thus, SymMap integrates TCM with modern medicine in common aspects at both the phenotypic and molecular levels. Furthermore, we inferred all pairwise relationships among SymMap components using statistical tests to give pharmaceutical scientists the ability to rank and filter promising results to guide drug discovery. The SymMap database can be accessed at http://www.symmap.org/ and https://www.bioinfo.org/symmap.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · cited 1×
“Furthermore, to control the false discovery rate (FDR) due to multiple tests, we calculated the FDRs according to both the Bonferroni (25) and the BH (26) methods from P-values.”
MethodTCMSP: a database of systems pharmacology for drug discovery from herbal medicines
Ru, J., Li, P., Wang, J., Zhou, W., Li, B., Huang, C., Li, P., Guo, Z., Tao, W., Yang, Y., et al. (2014) · Journal of Cheminformatics · doi:10.1186/1758-2946-6-13 · Cited by 5,038
DrugBank: a comprehensive resource for in silico drug discovery and exploration
Wishart, D. S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj067 · Cited by 3,892
Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders
Hamosh, A. (2004) · Nucleic Acids Research · doi:10.1093/nar/gki033 · Cited by 3,420
Multiple significance tests: the Bonferroni method
Bland, J. M., & Altman, D. G. (1995) · BMJ · doi:10.1136/bmj.310.6973.170 · Cited by 3,341
On the Interpretation of χ 2 from Contingency Tables, and the Calculation of P
Fisher, R. A. (1922) · Journal of the Royal Statistical Society · doi:10.2307/2340521 · Cited by 2,953
Natural products: A continuing source of novel drug leads
Cragg, G. M., & Newman, D. J. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.02.008 · Cited by 2,906
The re-emergence of natural products for drug discovery in the genomics era
Harvey, A. L., Edrada-Ebel, R., & Quinn, R. J. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4510 · Cited by 2,572
How were new medicines discovered?
Swinney, D. C., & Anthony, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3480 · Cited by 1,812
The SIDER database of drugs and side effects
Kuhn, M., Letunic, I., Jensen, L. J., & Bork, P. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1075 · Cited by 1,451
The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine
Tu, Y. (2011) · Nature Medicine · doi:10.1038/nm.2471 · Cited by 1,392
The Human Phenotype Ontology in 2017
Köhler, S., Vasilevsky, N. A., Engelstad, M., Foster, E., McMurry, J., Aymé, S., Baynam, G., Bello, S. M., Boerkoel, C. F., Boycott, K. M., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1039 · Cited by 754
Gene: a gene-centered information resource at NCBI
Brown, G. R., Hem, V., Katz, K. S., Ovetsky, M., Wallin, C., Ermolaeva, O., Tolstoy, I., Tatusova, T., Pruitt, K. D., Maglott, D. R., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1055 · Cited by 699
Human symptoms–disease network
Zhou, X., Menche, J., Barabási, A.-L., & Sharma, A. (2014) · Nature Communications · doi:10.1038/ncomms5212 · Cited by 653
Self-citationNetwork-based in silico drug efficacy screening
Guney, E., Menche, J., Vidal, M., & Barábasi, A.-L. (2016) · Nature Communications · doi:10.1038/ncomms10331 · Cited by 625 · cited 1×
“To remove possible false positives, we used Fisher’s Exact Test (23) to obtain reliable associations with statistical significance, and Fisher’s exact test is effective and widely used for evaluating the reliability of biomedical associations (24).”
MethodTCMID: traditional Chinese medicine integrative database for herb molecular mechanism analysis
Xue, R., Fang, Z., Zhang, M., Yi, Z., Wen, C., & Shi, T. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1100 · Cited by 617
Phenotypic vs. Target-Based Drug Discovery for First-in-Class Medicines
Swinney, D. C. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.236 · Cited by 413
TCMID 2.0: a comprehensive resource for TCM
Huang, L., Xie, D., Yu, Y., Liu, H., Shi, Y. X., Shi, T., & Wen, C. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1028 · Cited by 411
Rath, A., Olry, A., Dhombres, F., Brandt, M. M., Urbero, B., & Ayme, S. (2012) · Human Mutation · doi:10.1002/humu.22078 · Cited by 382
HIT: linking herbal active ingredients to targets
Ye, H., Ye, L., Kang, H., Zhang, D., Tao, L., Tang, K., Liu, X., Zhu, R., Liu, Q., Chen, Y. Z., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1165 · Cited by 333
Qiu, J. (2007) · Nature · doi:10.1038/448126a · Cited by 315
Chen, X., Zhou, H., Liu, Y. B., Wang, J. F., Li, H., Ung, C. Y., Han, L. Y., Cao, Z. W., & Chen, Y. Z. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706945 · Cited by 226
Self-citationUMLS Concept Indexing for Production Databases: A Feasibility Study
Nadkarni, P., Chen, R., & Brandt, C. (2001) · Journal of the American Medical Informatics Association · doi:10.1136/jamia.2001.0080080 · Cited by 128
ヒトのオンラインメンデル性遺伝(OMIM),ヒト遺伝子および遺伝子病の情報ベース
Hamosh, A., Scott, A. F., Amberger, J. S., Bocchini, C. A., & McKusick, V. A. (2005) · Nucleic Acids Research · Cited by 104
Cited by
Zhao, L., Zhang, H., Li, N., Chen, J., Xu, H., Wang, Y., & Liang, Q. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116306 · Cited by 963
Self-citationHERB: a high-throughput experiment- and reference-guided database of traditional Chinese medicine
Fang, S., Dong, L., Liu, L., Guo, J., Zhao, L., Zhang, J., Bu, D., Liu, X., Huo, P., Cao, W., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1063 · Cited by 690
Self-citationZhang, P., Zhang, D., Zhou, W., Wang, L., Wang, B., Zhang, T., & Li, S. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad518 · Cited by 675
WANG, X., WANG, Z.-Y., ZHENG, J.-H., & LI, S. (2021) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(21)60001-8 · Cited by 545
Khan, T., Ali, M., Khan, A., Nisar, P., Jan, S. A., Afridi, S., & Shinwari, Z. K. (2019) · Biomolecules · doi:10.3390/biom10010047 · Cited by 375
Metadata
- Authors
- Wu, Y., Zhang, F., Yang, K., Fang, S., Bu, D., Li, H., Sun, L., Hu, H., Gao, K., Wang, W., Zhou, X., Zhao, Y., & Chen, J.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-10-31
- Volume
- 47
- Issue
- D1
- Pages
- D1110-D1117
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2899291554
- Cited by
- 561
- References
- 24
- FWCI
- 43.80
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.